Efficacy and safety of telitacicept in IgA nephropathy: real-world study outcomes
Efficacy and safety of telitacicept in IgA nephropathy: real-world study outcomes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy and safety of telitacicept in IgA nephropathy: real-world study outcomes have?
Efficacy and safety of telitacicept in IgA nephropathy: real-world study outcomes has 18 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy and safety of telitacicept in IgA nephropathy: real-world study outcomes published?
Efficacy and safety of telitacicept in IgA nephropathy: real-world study outcomes has 2025 year in the ScholarIQ index.
What is the open-access status of Efficacy and safety of telitacicept in IgA nephropathy: real-world study outcomes?
Efficacy and safety of telitacicept in IgA nephropathy: real-world study outcomes has gold oa status in the ScholarIQ index.
What is the DOI of Efficacy and safety of telitacicept in IgA nephropathy: real-world study outcomes?
The DOI for Efficacy and safety of telitacicept in IgA nephropathy: real-world study outcomes is on the source record.
What is the PMID of Efficacy and safety of telitacicept in IgA nephropathy: real-world study outcomes?
The PMID for Efficacy and safety of telitacicept in IgA nephropathy: real-world study outcomes is on the source record.
What is the OpenAlex record for Efficacy and safety of telitacicept in IgA nephropathy: real-world study outcomes?
The OpenAlex for Efficacy and safety of telitacicept in IgA nephropathy: real-world study outcomes is on the source record.